Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tolazoline hydrochloride (NSC35110 (hydrochloride)) is a non-selective competitive α-adrenergic receptor antagonist used in treatment of persistent pulmonary hypertension of the newborn.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 39.00 | |
1 g | In stock | $ 57.00 | |
5 g | In stock | $ 117.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | Tolazoline hydrochloride (NSC35110 (hydrochloride)) is a non-selective competitive α-adrenergic receptor antagonist used in treatment of persistent pulmonary hypertension of the newborn. |
In vivo | In cases of persistent pulmonary hypertension of the newborn (PPHN), Tolazoline acts as a pulmonary vasodilator, effectively reducing pulmonary vascular resistance (PVR) and pulmonary arterial pressure. Additionally, within the human radial artery, Tolazoline blocks α-adrenergic activity, significantly counteracting vascular spasms. |
Synonyms | Imidaline hydrochloride, Imidaline (hydrochloride), Benzidazol hydrochloride, Tolazoline HCl, NSC35110 (hydrochloride) |
Molecular Weight | 196.68 |
Formula | C10H13ClN2 |
CAS No. | 59-97-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 36 mg/mL (183 mM)
DMSO: 37 mg/mL (188.1 mM)
Ethanol: 37 mg/mL (188.1 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tolazoline hydrochloride 59-97-2 GPCR/G Protein Neuroscience Adrenergic Receptor Tolazoline Hydrochloride Imidaline hydrochloride inhibit Imidaline Hydrochloride NSC35110 Imidaline Beta Receptor Benzidazol Hydrochloride Inhibitor Imidaline (hydrochloride) Benzidazol hydrochloride Tolazoline HCl NSC35110 (hydrochloride) NSC-35110 Tolazoline NSC 35110 inhibitor